Market Closed -
Xetra
11:35:24 2024-07-05 am EDT
|
5-day change
|
1st Jan Change
|
33.1
EUR
|
+0.30%
|
|
-1.05%
|
+2.00%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
5,846
|
5,858
|
4,921
|
4,183
|
4,897
|
4,927
|
-
|
-
|
Enterprise Value (EV)
1 |
5,639
|
5,679
|
4,824
|
4,243
|
4,785
|
4,735
|
4,559
|
4,422
|
P/E ratio
|
26.9
x
|
29.2
x
|
21.8
x
|
17.4
x
|
19.3
x
|
17.9
x
|
16.2
x
|
15.2
x
|
Yield
|
2.2%
|
2.13%
|
2.58%
|
3.27%
|
2.75%
|
2.77%
|
2.92%
|
3.06%
|
Capitalization / Revenue
|
2.27
x
|
2.46
x
|
1.71
x
|
1.23
x
|
1.38
x
|
1.37
x
|
1.32
x
|
1.27
x
|
EV / Revenue
|
2.19
x
|
2.39
x
|
1.68
x
|
1.24
x
|
1.35
x
|
1.32
x
|
1.22
x
|
1.14
x
|
EV / EBITDA
|
14.5
x
|
14.8
x
|
10.7
x
|
9.24
x
|
9.36
x
|
8.98
x
|
8
x
|
7.43
x
|
EV / FCF
|
32.2
x
|
23.9
x
|
54.2
x
|
69.6
x
|
10.3
x
|
15.9
x
|
14.4
x
|
13.6
x
|
FCF Yield
|
3.1%
|
4.19%
|
1.85%
|
1.44%
|
9.72%
|
6.29%
|
6.94%
|
7.36%
|
Price to Book
|
3.93
x
|
4.09
x
|
3.17
x
|
2.48
x
|
3.11
x
|
2.85
x
|
2.59
x
|
2.36
x
|
Nbr of stocks (in thousands)
|
139,000
|
139,000
|
139,000
|
138,190
|
134,629
|
131,520
|
-
|
-
|
Reference price
2 |
44.16
|
46.44
|
39.92
|
32.74
|
40.30
|
41.82
|
41.82
|
41.82
|
Announcement Date
|
2/20/20
|
3/9/21
|
3/18/22
|
3/8/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
2,572
|
2,378
|
2,871
|
3,412
|
3,541
|
3,587
|
3,746
|
3,887
|
EBITDA
1 |
389
|
383
|
449
|
459
|
511
|
527.1
|
569.5
|
595.4
|
EBIT
1 |
321
|
313
|
363
|
365
|
413
|
440.9
|
484.8
|
512.9
|
Operating Margin
|
12.48%
|
13.16%
|
12.64%
|
10.7%
|
11.66%
|
12.29%
|
12.94%
|
13.19%
|
Earnings before Tax (EBT)
1 |
317
|
308
|
358
|
357
|
403
|
431.5
|
475.1
|
507.5
|
Net income
1 |
228
|
220
|
253
|
259
|
282
|
309.2
|
340.5
|
362.6
|
Net margin
|
8.86%
|
9.25%
|
8.81%
|
7.59%
|
7.96%
|
8.62%
|
9.09%
|
9.33%
|
EPS
2 |
1.640
|
1.590
|
1.830
|
1.880
|
2.090
|
2.335
|
2.585
|
2.749
|
Free Cash Flow
1 |
175
|
238
|
89
|
61
|
465
|
297.7
|
316.5
|
325.6
|
FCF margin
|
6.8%
|
10.01%
|
3.1%
|
1.79%
|
13.13%
|
8.3%
|
8.45%
|
8.38%
|
FCF Conversion (EBITDA)
|
44.99%
|
62.14%
|
19.82%
|
13.29%
|
91%
|
56.48%
|
55.58%
|
54.69%
|
FCF Conversion (Net income)
|
76.75%
|
108.18%
|
35.18%
|
23.55%
|
164.89%
|
96.29%
|
92.96%
|
89.79%
|
Dividend per Share
2 |
0.9700
|
0.9900
|
1.030
|
1.070
|
1.110
|
1.157
|
1.223
|
1.280
|
Announcement Date
|
2/20/20
|
3/9/21
|
3/18/22
|
3/8/23
|
3/12/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
1,411
|
742
|
808
|
832
|
1,640
|
902
|
870
|
936
|
946
|
1,882
|
816
|
843
|
877
|
881
|
-
|
879.5
|
831.4
|
916.6
|
908.5
|
EBITDA
1 |
-
|
107
|
-
|
-
|
-
|
124
|
109
|
-
|
-
|
-
|
-
|
125
|
131
|
135.6
|
-
|
133.6
|
115.9
|
140
|
138.9
|
EBIT
|
191
|
84
|
93
|
87
|
180
|
100
|
85
|
103
|
97
|
200
|
133
|
100
|
107
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
13.54%
|
11.32%
|
11.51%
|
10.46%
|
10.98%
|
11.09%
|
9.77%
|
11%
|
10.25%
|
10.63%
|
16.3%
|
11.86%
|
12.2%
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
99
|
106
|
115.9
|
-
|
113.9
|
95.88
|
119.9
|
119.2
|
Net income
1 |
-
|
56
|
67
|
61
|
128
|
70
|
61
|
73
|
68
|
141
|
77
|
64
|
77
|
80.18
|
156.3
|
79.62
|
66.99
|
83.72
|
83.19
|
Net margin
|
-
|
7.55%
|
8.29%
|
7.33%
|
7.8%
|
7.76%
|
7.01%
|
7.8%
|
7.19%
|
7.49%
|
9.44%
|
7.59%
|
8.78%
|
9.1%
|
-
|
9.05%
|
8.06%
|
9.13%
|
9.16%
|
EPS
2 |
0.9800
|
0.4100
|
0.4800
|
0.4500
|
0.9300
|
0.5000
|
0.4500
|
0.5400
|
0.5000
|
1.040
|
0.5800
|
0.4700
|
0.5800
|
0.5900
|
1.180
|
-
|
-
|
0.6285
|
0.6245
|
Dividend per Share
2 |
-
|
1.030
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.110
|
-
|
-
|
-
|
-
|
1.155
|
-
|
-
|
Announcement Date
|
7/30/21
|
3/18/22
|
4/29/22
|
7/29/22
|
7/29/22
|
10/28/22
|
3/8/23
|
4/28/23
|
7/28/23
|
7/28/23
|
10/27/23
|
3/12/24
|
4/30/24
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
60
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
207
|
179
|
97
|
-
|
112
|
192
|
367
|
504
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.1307
x
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
175
|
238
|
89
|
61
|
465
|
298
|
317
|
326
|
ROE (net income / shareholders' equity)
|
15.1%
|
14%
|
15.2%
|
14.4%
|
15.5%
|
16.3%
|
16.5%
|
16%
|
ROA (Net income/ Total Assets)
|
11.7%
|
10.6%
|
11.4%
|
10.7%
|
11.4%
|
12.6%
|
13.5%
|
13.2%
|
Assets
1 |
1,957
|
2,072
|
2,216
|
2,417
|
2,473
|
2,456
|
2,520
|
2,741
|
Book Value Per Share
2 |
11.20
|
11.40
|
12.60
|
13.20
|
12.90
|
14.70
|
16.20
|
17.70
|
Cash Flow per Share
2 |
2.370
|
2.590
|
2.590
|
0.9200
|
4.030
|
2.380
|
2.690
|
2.720
|
Capex
1 |
154
|
122
|
80
|
69
|
83
|
79.4
|
86.4
|
93.1
|
Capex / Sales
|
5.99%
|
5.13%
|
2.79%
|
2.02%
|
2.34%
|
2.21%
|
2.31%
|
2.4%
|
Announcement Date
|
2/20/20
|
3/9/21
|
3/18/22
|
3/8/23
|
3/12/24
|
-
|
-
|
-
|
Last Close Price
41.82
EUR Average target price
49.3
EUR Spread / Average Target +17.89% Consensus |
1st Jan change
|
Capi.
|
---|
| +2.09% | 103B | | -11.38% | 59.18B | | +75.24% | 48.74B | | +5.57% | 34.98B | | -1.58% | 30.99B | | +1.46% | 18.53B | | +17.54% | 17.42B | | +6.83% | 13.32B | | +80.76% | 13.19B |
Other Commodity Chemicals
|